Avid Bioservices Inc (CDMO)

[stockaxe]

I disagree, and I already laid out the math on why they don't need more capital. The Company is about to be a cash machine, generating >$100mm of EBITDA per year with minimal maintenance capital spending. Cash from operations alone can fund any new growth. Or, if something really big came along, they could easily go to 3-4x leverage on their EBITDA and raise $300mm+ in low cost debt.